US Stock MarketDetailed Quotes
NUWE Nuwellis
- 1.8400
- -0.9700-34.52%
Close Nov 5 16:00 ET
- 1.6900
- -0.1500-8.15%
Pre 04:55 ET
3.44MMarket Cap-15P/E (TTM)
2.5000High1.8000Low5.94MVolume2.5000Open2.8100Pre Close12.05MTurnover318.06%Turnover RatioLossP/E (Static)1.87MShares31.150052wk High-0.50P/B3.43MFloat Cap1.000052wk Low--Dividend TTM1.87MShs Float6085800000.0000Historical High--Div YieldTTM24.91%Amplitude1.0000Historical Low2.0290Avg Price1Lot Size
About Nuwellis Company
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
Company Profile
SymbolNUWE
Company NameNuwellis
Listing DateFeb 16, 2012
Founded1999
CEOMr. Nestor Jaramillo, Jr
MarketNASDAQ
Employees59
Fiscal Year Ends12-31
Address12988 Valley View Road
CityEden Prairie
ProvinceMinnesota
CountryUnited States of America
Zip Code55344
Phone1-952-345-4200
Company Executives
- Name
- Position
- Salary
- Nestor Jaramillo, Jr
- Director, President and Chief Executive Officer
- 606.60K
- Robert Benjamin Scott
- Chief Financial Officer and Principal Accounting Officer
- 291.41K
- Neil P. Ayotte, Esq.
- Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
- 406.49K
- John L. Erb
- Chairman of the Board
- 65.86K
- Dr. Maria Rosa Costanzo, M.D.
- Independent Director
- 53.79K
- Michael McCormick
- Lead Independent Director
- 25.66K
- Gregory D. Waller
- Independent Director
- 68.86K
- David Alan McDonald
- Independent Director
- --
- Dr. Archelle Georgiou, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
